US healthcare giant Johnson & Johnson has announced new long-term data from the QUASAR late-term study showing that Tremfya ...
Israel-based generics giant Teva Industries and France’s Medincell announced that the US Food and Drug Administration has accepted the New Drug Application for olanzapine extended-release injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results